Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

Size: px
Start display at page:

Download "Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College"

Transcription

1 Prevention of Medication-Related Falls Through Appropriate Medication Use Clay Sprouse, MEd., CPhT Piedmont Technical College

2 Disclosure I have no relevant financial or nonfinancial relationships to disclose as it relates to this presentation.

3 Objectives At the completion of this activity, the pharmacy technician will be able to: Describe the influence of age-related drug metabolism on the risk of falling Describe potential side effects of at least 2 classes with high risk medications associated with increased fall risk in older adults Identify risk factors for falling in older adults Utilize fall risk assessment tools to evaluate medication-related fall risk Explore at least 2 fall prevention strategies

4 Introduction Unintentional falls are the leading cause of fatal and nonfatal injuries in older adults CDC says older adults accounted for over 25% of all hospital ED visits related to unintentional falls 28-40% of community dwelling older adults over the age of 65 will sustain one or more falls in a year Falls are associated with serious health consequences such as fractures, disability and loss of independence

5 Introduction continued Proactive strategies such as multifactorial risk assessment partnered with a targeted intervention has shown most success in reducing falls in older adults With increased knowledge, pharmacy personnel can play an important role

6 ADME and its effects on Falls Absorption, Distribution, Metabolism, Elimination Absorption in older adults may be altered due to age-related changes in gastric ph or GI motility Older adults are also more susceptible to drug induced changes in absorption For example, PPI and antacids may inhibit the absorption of other critical medications taken in older age Changes in distribution occur as a result of a decrease in total body water and lean muscle mass Decrease in total body water results in increased concentrations of water soluble meds such as digoxin and lithium Can increase risk of falls due to effects such as dizziness and blurred vision Meds like benzodiazepines pose a fall risk related to their prolonged half-life in older adults related to an increase in body fat with age

7 ADME and its effects on Falls (continued) As adults age, decrease in liver size and blood flow can alter drug clearance As a result, medications that undergo extensive first-pass metabolism or require activation in the liver may be altered in older adults Propranolol undergoes extensive first-pass metabolism and has an increased bioavailability in older adults which could lead to increased hypertension or symptomatic hypotension, therefore falls occurring Renal blood flow, tubular function, and filtration rates all decline with increasing age Many examples of renal eliminated meds that can accumulate and predispose older adults to adverse effects associated with falls Morphine is eliminated through the renal system. If there are issues with elimination, side effects such as sedation, dizziness and confusion can increase leading to a major increase in risk of falls

8 High Fall Risk Medications Psychotropic medications encompass several classes of medications commonly used in older adults including antidepressants, anticonvulsants, antipsychotics, benzodiazepines, sedative/hypnotics and opioid analgesics One community based study had use of any psychotropic agent by older adults increased the risk of falls by 47%

9 High Fall Risk Medications First and second generation antipsychotics can cause sedation and orthostatic hypotension Long term use of antipsychotics has been shown to increase fall risk by 81% compared to short term use Sedatives/hypnotics can cause cognitive impairment, sedation and confusion. Benzos are associated with an increased fall risk after a new start and with long term use Non-benzodiazepine sedatives/hypnotics, such as zolpidem, have a similar side effect profile

10 High Fall Risk Medications Antidepressants can cause ataxia (loss of body movement), hypotension and syncope (temporary loss of consciousness) Little difference in fall and fracture risk between SSRI and tricyclic antidepressants Older adults should be monitored when first starting antidepressants, with dosage adjustments and long-term use Opioid analgesics, such as morphine, hydromorphone, fentanyl, and oxycodone can cause dizziness, syncope, and CNS depression Studies have mixed results but several have shown increased fall risk Risk increased when used with other meds that show high fall risk

11 High Fall Risk Medications Other classes have been studied and shown to increase fall risk in older adults Anticonvulsants, cardiac meds, NSAIDS Many of these meds have been associated with recurrent and injurious falls

12 Fall Risk in Older Adults Falls in community dwelling older adults is a common geriatric syndrome Absolute risk of falls in study participants ranged from 11% in older adults with no risk factors to 54% in patients with multiple risk factors Older adults are at risk of falls and risk is correlated with the number of risk factors Clinical practice guidelines recommend that all older adults over 65 be routinely screened for history of falls to identify patients that may be high risk and could benefit from intervention

13 Fall Risk in Older Adults Risk Factors include: History of falls Orthostatic hypotension Balance disturbances Decreased mobility/poor muscle strength Visual impairment Unsuitable footwear Use of psychotropic medications Limited functional status Cognitive or other neurologic impairments

14 Risk Assessment Tools AGS (American Geriatric Association) identifying PIMs (potentially inappropriate medications) The tool organizes PIMs into 3 tables: organ system/therapeutic category, drug-disease/drug-syndrome interactions, and drugs to be used with caution Tool is available as a pocket card and may be used in any practice setting to assist with evaluating appropriateness of a older adult s edicatio regimen and risk of falls

15 Risk Assessment Tools Tool 31: Medication Fall Risk Score and Evaluation Tool Developed for hospitalized patients but can easily be used in other settings 3 tier risk factor identification Point value system based on medications fall risk potential Score of 6 or higher is a high risk for falls

16 Assessment in the Community Pharmacy Older adults at high risk, particularly those with a history of recurrent falls receive targeted interventions in areas of strength and balance, home safety, vision assessment and medication management Community pharmacies are uniquely qualified and positioned to recommend targeted medication interventions and provide education to prevent medication-related falls in community dwelling older adults

17 Assessment in the Community Pharmacy Medication regimen review Minimize use of psychotropic medications and other high risk medications Interventions to prevent postural hypotension Vitamin D supplementation Education of fall prevention

18 Minimize Use of High Risk Management Patient specific medication review Several studies that included medication reviews as part of a multifactorial intervention showed a significant reduction in falls Reducing psychotropic use demonstrated multiple health benefits including fewer falls, improved functional status and less cognitive decline Pharmacists and pharmacy technicians can make recommendations to reduce or eliminate use of psychotropic and other inappropriate medications (implementation of nonpharmacologic strategies or opting for medications with fewer adverse effects)

19 Vitamin D Supplementation Older adults are at increased risk of vitamin D deficiency which is associated with increased fall risk According to US Preventative Services Task force recommends 400 to 600 units of vita i D i to older adults diets Multivitamin or vitamin D supplement is recommended Instructions on use and varieties available

20 Education and Counseling Encourage all older adults to participate in fall prevention programs Group programs and individualized counseling should be considered as part of an effective fall prevention strategy Healthinaging.org provides materials geared towards the health of older adults cdc.gov has the STEADI (Stopping Elderly Accidents, Deaths & Injuries) Toolkit CDC has developed a series of brochures and posters geared towards involving older adults and preventing falls National Institute of Aging has information on fall prevention

21 Summary Age-related changes, co-morbid conditions and inappropriate medication use increases the risk of falls in older adults Pharmacy personnel collaborating with the healthcare team can help ensure appropriate medication use Conducting medication reviews for high risk older adults Screening and appropriate counseling on high risk meds may reduce risk in vulnerable adults Pharmacies that serve large geriatric population may be successful in developing fall prevention programs

22 Class Assessment Which of the following classes is associated with the highest risk of falls in older adults? A. Antipsychotics B. Anti-hypertensives C. Diuretics D. NSAIDS Benzodiazepines can cause which of the following adverse effects that can increase risk of falls in older adults? A. Sedation B. Cognitive Impairment C. Delirium D. All of the Above

23 Class Assessment Medications that undergo extensive - metabolism or require activation in the liver may be altered in older adults. Side effects of analgesic opioids can include all of the following except: A. Syncope B. Dizziness C. Central Nervous System Depression D. All of the Above

24 Class Assessment True/False: Co ditio of a patie t s shoes could determine risk for a fall. True/False: Patients with a fall history will likely not suffer from any other falls.

25 Class Assessment Several studies that included as part of a multifactorial intervention showed a significant reduction in falls. The Centers for Disease Control provides a free toolkit to assist healthcare providers and patients in the prevention of accidents and falls called STEADI. STEADI stands for.

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who

More information

Pharmacology in the Elderly

Pharmacology in the Elderly Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol

More information

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy

START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy START, STOPP, Beers Oh My! Navigating the World of Geriatric Pharmacy Jessica DiLeo, PharmD Kate Murphy, PharmD OBJECTIVES Identify pharmacodynamic and pharmacokinetic parameters that may influence treatment

More information

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion

More information

The role of medication in falls risk

The role of medication in falls risk The role of medication in falls risk Patrick A. Ball, Foundation Professor of Rural Pharmacy, Charles Sturt University, Wagga Wagga Lecture outline The aged are not created equal Insidious nature of onset

More information

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD

Family Medicine for English language students of Medical University of Lodz. Seminar 12. Elderly care. Przemysław Kardas MD PhD Family Medicine for English language students of Medical University of Lodz Seminar 12 Elderly care Przemysław Kardas MD PhD Europe is facing demographic challenge 2014 2080 2 3 Old vs young: major differences

More information

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics

More information

Medication Use in Older Adults

Medication Use in Older Adults Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division

More information

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE I have no financial conflict of interest to disclose. Lacey Charbonneau, Pharm.D. PGY-1 Community Practice Resident Baptist Medical

More information

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria

More information

FALLS PREVENTION. S H I R L E Y H U A N G, M S c, M D, F R C P C

FALLS PREVENTION. S H I R L E Y H U A N G, M S c, M D, F R C P C FALLS PREVENTION S H I R L E Y H U A N G, M S c, M D, F R C P C S T A F F G E R I A T R I C I A N T H E O T T A W A H O S P I T A L B R U Y E R E C O N T I N U I N G C A R E W I N C H E S T E R D I S T

More information

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney

More information

Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients. Danielle Hansen, DO, MS (Med Ed), MHSA

Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients. Danielle Hansen, DO, MS (Med Ed), MHSA Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients Danielle Hansen, DO, MS (Med Ed), MHSA Clinical Assistant Professor, LECOM Associate Director, LECOM Institute for Successful

More information

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)

More information

Objectives. 0 Identify medicines which increase the risk of falls and secondary injury on the farm/ranch.

Objectives. 0 Identify medicines which increase the risk of falls and secondary injury on the farm/ranch. Objectives 0 Identify medicines which increase the risk of falls and secondary injury on the farm/ranch. 0 Examine the impact of a medication assessment service on Missouri AgrAbility clients confidence

More information

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS Philip J. Schneider, MS, FASHP The University of Arizona College of Pharmacy Learning Objectives: Describe the medication-use system and all interdependent

More information

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

Rational prescribing in the older adult. Assoc Prof Craig Whitehead Rational prescribing in the older adult Assoc Prof Craig Whitehead Introduction Physioloical ageing and frailty Medication risks in older adults Drug Burden Anticholinergic and sedative drug burden Cascade

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Prescribing Drugs to the Elderly

Prescribing Drugs to the Elderly Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering

More information

Multifactorial risk assessments and evidence-based interventions to address falls in primary care. Objectives. Importance

Multifactorial risk assessments and evidence-based interventions to address falls in primary care. Objectives. Importance Multifactorial risk assessments and evidence-based interventions to address falls in primary care Sarah Ross, DO, MS Assistant Professor Internal Medicine, Geriatrics Nicoleta Bugnariu, PT, PhD Associate

More information

A Step Forward: Promoting Independence through Falls Prevention

A Step Forward: Promoting Independence through Falls Prevention A Step Forward: Promoting Independence through Falls Prevention 2014 Geriatric Update Meharry Consortium Geriatric Education Center A Step Forward: Promoting Independence through Falls Prevention Moderator:

More information

Fall Risk Assessment and Management. Elizabeth A. Phelan, MD, MS Assistant Professor, Medicine/Gerontology October 24, 2007

Fall Risk Assessment and Management. Elizabeth A. Phelan, MD, MS Assistant Professor, Medicine/Gerontology October 24, 2007 Fall Risk Assessment and Management Elizabeth A. Phelan, MD, MS Assistant Professor, Medicine/Gerontology October 24, 2007 Slide 2 OBJECTIVES Know and understand: The importance of falls by older persons

More information

Pain Management in the Elderly. Martha Watson, MS, APRN, GCNS Christie Bowser, RN-BC, RN

Pain Management in the Elderly. Martha Watson, MS, APRN, GCNS Christie Bowser, RN-BC, RN Pain Management in the Elderly Martha Watson, MS, APRN, GCNS Christie Bowser, RN-BC, RN Objectives So How Much Do You Really Know? www.geriatricpain.org Geriatric Pain Knowledge Assessment The Geriatric

More information

Reduction of High Risk Medications Using A Quality Initiative Perspective

Reduction of High Risk Medications Using A Quality Initiative Perspective Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what

More information

PREVENTIVE CARE GUIDELINE. Quality Management Committee Chair

PREVENTIVE CARE GUIDELINE. Quality Management Committee Chair PREVENTIVE CARE GUIDELINE Guideline Number: DHMP_DHMC_PG1008 Effective Date: 11/2016 Guideline Subject: Fall Prevention Guideline for 65+ & Above Revision Date: 11/2017 Page 2 of 4 Quality Management Committee

More information

Pharmacotherapy In Geriatrics: Cause For Concern

Pharmacotherapy In Geriatrics: Cause For Concern http://www.dcmsonline.org/jax-medicine/1998journals/august98/geriatrics.htm Pharmacotherapy In Geriatrics: Cause For Concern Sherry A. King, M.D. Sherry A. King, M.D. is Clinical Assistant Professor of

More information

Falls Injury Prevention in Residential Care

Falls Injury Prevention in Residential Care in Residential Care Guide to Best Practice Prepared by Mandy Harden and John Ward, HNE Health, Nov, 2010. Epidemiology About one-third of all hip fractures occur in aged care facilities Many people with

More information

Prescribing and Pharmacokinetic Considerations in the Elderly

Prescribing and Pharmacokinetic Considerations in the Elderly Prescribing and Pharmacokinetic Considerations in the Elderly Melanie A. Dodd, Pharm.D., Ph.C., BCPS Associate Professor of Pharmacy in Geriatrics College of Pharmacy The University of New Mexico OBJECTIVES

More information

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP Dementia and Fall Geriatric Interprofessional Training Wael Hamade, MD, FAAFP Prevalence of Dementia Age range 65-74 5% % affected 75-84 15-25% 85 and older 36-50% 5.4 Million American have AD Dementia

More information

Workshop 4: Preventing Falls through Medication Vigilance

Workshop 4: Preventing Falls through Medication Vigilance Workshop 4: Preventing Falls through Medication Vigilance Nancy L. Losben, R.Ph., CCP, FASCP, CG Chief Quality Officer Omnicare, Inc. & Diane C. Vaughn, RN, C-DONA/LTC, LNHA VP, Clinical Services Benedictine

More information

Potential Drug Dosing Variability in Women. Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital

Potential Drug Dosing Variability in Women. Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital Potential Drug Dosing Variability in Women Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital 2 Objectives Understand the pharmacokinetic variability

More information

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016 Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Meds and Falls: Keep in Step with your Meds

Meds and Falls: Keep in Step with your Meds Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu

More information

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Target Audience: Pharmacists ACPE#: 0202-9999-18-056-L01-P Activity Type: Application-based Disclosures Kathleen

More information

Blueprint for Prescriber Continuing Education Program

Blueprint for Prescriber Continuing Education Program CDER Final 10/25/11 Blueprint for Prescriber Continuing Education Program I. Introduction: Why Prescriber Education is Important Health care professionals who prescribe extended-release (ER) and long-acting

More information

What are you trying to achieve? Falls Prevention, Assessment and Management Strategies. Falls can be classified into four main groups:

What are you trying to achieve? Falls Prevention, Assessment and Management Strategies. Falls can be classified into four main groups: What are you trying to achieve? Falls Prevention, Assessment and Management Strategies Dr Adam Darowski Community: Falls risk assessment: Falls risk is 50% per year in 80yr population and higher in those

More information

Fact Sheet. Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII

Fact Sheet. Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII Fact Sheet Zohydro ER (hydrocodone bitartrate) Extended-Release Capsule, CII, is a long-acting (extendedrelease) type of pain medication

More information

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients

There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients There s A Pill For That (But should my patient be on it?) A Review of Tools for the Evaluation of Optimal Prescribing in Geriatric Patients Marilyn N. Bulloch, PharmD, BCPS Assistant Clinical Professor

More information

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid Definition All drugs, natural or synthetic, that bind to opiate receptors Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone Opioid agonists increase pain threshold

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

Pharmaceutical Care for Geriatrics

Pharmaceutical Care for Geriatrics Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING

More information

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine A Geriatrician s Perspective on Successful Aging Ariel Green, MD, MPH Assistant Professor of Medicine 1 Disclosures Johns Hopkins Clinical Research Scholars Program American College of Cardiology Foundation

More information

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP

Polypharmacy. in the Elderly. Lesley Charles, MBChB, CCFP Polypharmacy in the Elderly Lesley Charles, MBChB, CCFP Associate Professor and Program Director Division of Care of the Elderly Department of Family Medicine, University of Alberta March 06, 2016 1 Faculty/Presenter

More information

Information for the use of medicines in the elderly

Information for the use of medicines in the elderly Information for the use of medicines in the elderly Geriatric Medicines Strategy EMA - Payer Community meeting Presented by Francesca Cerreta An agency of the European Union Population pyramid, EU-28,

More information

Polypharmacy: Guidance for Prescribing in Frail Adults

Polypharmacy: Guidance for Prescribing in Frail Adults Polypharmacy: Guidance for Prescribing in Frail Adults Why is reviewing polypharmacy important? Medication is by far the most common form of medical intervention. Four out of five people aged over 75 years

More information

Pain Management in Older Adults. Mary Shelkey, PhD, ARNP

Pain Management in Older Adults. Mary Shelkey, PhD, ARNP Pain Management in Older Adults Mary Shelkey, PhD, ARNP Cause of Death/ Demographic and Social Trends Early 1900s Current Medicine's Focus Comfort Cure Cause of Death Infectious Diseases/ Communicable

More information

Keep them STEADI: Implementation of a Hospital-Based Fall Prevention Program

Keep them STEADI: Implementation of a Hospital-Based Fall Prevention Program Keep them STEADI: Implementation of a Hospital-Based Fall Prevention Program Older Adult Falls 1 out of 3 older adults (65 yrs or greater) fall each year In 2010, 2.3 million nonfatal fall injuries among

More information

Prescribing for older people

Prescribing for older people Search Student BMJ Search Student BMJ Education Prescribing for older people What do you need to be aware of when prescribing for elderly people? Louise E Cotter and Una Martin discuss By: Louise E Cotter,

More information

Deprescribing Unnecessary Medications: A Four-Part Process

Deprescribing Unnecessary Medications: A Four-Part Process Deprescribing Unnecessary Medications: A Four-Part Process Scott Endsley, MD Fam Pract Manag. 2018;25(3):28-32. Abstract and Introduction Introduction www.medscape.com Ms. Horatio is a 76-year-old patient

More information

Medication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island

Medication Assessment and Quality Parameters. Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island Medication Assessment and Quality Parameters Norma J. Owens, PharmD, FCCP Professor of Pharmacy University of Rhode Island Financial Disclosure None of the planners, speakers, and/or members of the CME

More information

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly Mary Lynn McPherson, PharmD, MDE, MA, BCPS, CPE Professor and Executive Director, Advanced Post-Graduate

More information

WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS

WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS DOPAMINE HYPOTHESIS Excessive limbic dopamine is hypothesised to cause psychosis Many antipsychotics inhibit dopamine 2 receptors in mesolimbic and

More information

Palliative and Hospice Care of the Terminally Ill Introduction

Palliative and Hospice Care of the Terminally Ill Introduction Palliative and Hospice Care of the Terminally Ill Introduction There has been an increase in life expectancy for men and women of all races to 77.6 years Leading causes of death in older patients are chronic

More information

Biology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation.

Biology of Aging. Faculty Disclosure. Learning Objectives. I have no relevant financial disclosures relative to the content of this presentation. Biology of Aging Aging Changes That Impact Medication Management Emily P. Peron, PharmD, MS, BCPS, FASCP Assistant Professor of Geriatrics Virginia Commonwealth University School of Pharmacy Richmond,

More information

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX

National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL or FAX National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie PRESCRIBING IN THE ELDERLY INTRODUCTION According to the most recent census

More information

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region

Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region Risks Of Polypharmacy Amal AL-Anazi, BSc.(Pharm) Medication Safety Officer In Eastern Region What is Polypharmacy? Polypharmacy means many drugs. In practice, polypharmacy refers to the use of more medication

More information

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of

More information

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Dopaminergic Drugs: Actions Symptoms of parkinsonism are caused by depletion of dopamine in CNS Amantadine: makes more of dopamine available

More information

Drug Therapy Following Bariatric Surgery

Drug Therapy Following Bariatric Surgery Drug Therapy Following Bariatric Surgery Linda F. McElhiney PharmD, RPh, MSP, FIACP, FACA, FASHP, DPLA Compounding Pharmacist Indiana University Health Disclosures Dr. McElhiney declare(s) no conflicts

More information

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Below is the form you need to fill out. NAME Dianne Vicary Health Hawke s Bay DATE JUNE 2012 TITLE OF ACTIVITY

More information

NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face.

NEW ZEALAND DATA SHEET ACUPAN TM. 3. PHARMACEUTICAL FORM White, round, biconvex, film-coated tablets (7 mm diameter) engraved APN on one face. 1. PRODUCT NAME ACUPAN 30 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains nefopam hydrochloride 30 mg. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM

More information

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day

More information

Definition and Statistics

Definition and Statistics Objectives 1. Describe the basic principles of how drugs work in the body and with one another. Nanette R Wrobel, RPh Director of Education/Clinical Director Pharmacy Alternatives 2. Identify the four

More information

Prescription Drug Misuse/Abuse in Seniors. April Rovero Founder/Executive Director

Prescription Drug Misuse/Abuse in Seniors. April Rovero Founder/Executive Director Prescription Drug Misuse/Abuse in Seniors April Rovero Founder/Executive Director Deaths per 100,000 Population 30 25 Overdose Demographics Drug Poisoning Death Rates by Age: United States (2010) 20 15

More information

STOPP START Toolkit Supporting Medication Review in the Older Person

STOPP START Toolkit Supporting Medication Review in the Older Person STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,

More information

Polypharmacy in Geriatrics

Polypharmacy in Geriatrics 179 Awareness Article Polypharmacy in Geriatrics T. Vishnuvaravidyadhar*, M. Sushma, R. Mohanraj, M. Babu Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education & Research (RIPER),

More information

Mellaril (thioridazine)

Mellaril (thioridazine) Generic name: Thioridazine Available strengths: 10 mg, 25 mg, 50 mg, 100 mg, 200 mg tablets; 30 mg/ml, 100 mg/ml oral concentrate Available in generic: Yes Drug class: First-generation (conventional) antipsychotic

More information

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY TRAPADOL INJECTION FOR I.V./I.M. USE ONLY Composition : Each 2ml. contains : Tramadol Hydrochloride I.P. Water for injection I.P. 100mg. q.s. CLINICAL PHARMACOLOGY : Pharmacodynamics Tramadol is a centrally

More information

Opioid Review and MAT Clinic CDC Guidelines

Opioid Review and MAT Clinic CDC Guidelines 1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are

More information

ESSENTIAL CARE AFTER AN IN-PATIENT FALL

ESSENTIAL CARE AFTER AN IN-PATIENT FALL ESSENTIAL CARE AFTER AN IN-PATIENT FALL In line with the National Patient Safety Agency Rapid Response Report (NPSA/2011/RRR001): Essential care after an inpatient fall, in caring for a patient who has

More information

Knock Out Opioid Abuse in New Jersey:

Knock Out Opioid Abuse in New Jersey: Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids

More information

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS Guideline Title Summary of Product Characteristics for Benzodiazepines as Anxiolytics or Hypnotics Legislative basis Directive

More information

Essential Shared Care Agreement: Lithium

Essential Shared Care Agreement: Lithium Ref No. E042 Essential Shared Care Agreement: Lithium Please complete the following details: Patient s name, address, date of birth Treatment (indication, dose regimen, brand name) Monitoring (proposed

More information

Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression

Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression SHARED CARE PROTOCOL AND INFORMATION FOR GPS Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression Version:

More information

Aging Changes That Impact Medication Management

Aging Changes That Impact Medication Management Biology of Aging Aging Changes That Impact Medication Management Emily P. Peron, PharmD, MS, BCPS, FASCP Assistant Professor of Geriatrics Virginia Commonwealth University School of Pharmacy Richmond,

More information

Tai Chi for Prevention of Falls in Older Adults. Yolanda Suarez, DO Geriatrics Fellow University of Reno School of Medicine June 20, 2018

Tai Chi for Prevention of Falls in Older Adults. Yolanda Suarez, DO Geriatrics Fellow University of Reno School of Medicine June 20, 2018 Tai Chi for Prevention of Falls in Older Adults Yolanda Suarez, DO Geriatrics Fellow University of Reno School of Medicine June 20, 2018 Through this interactive presentation you will learn to Identify

More information

Symptom Management Challenges at End-of-Life

Symptom Management Challenges at End-of-Life Symptom Management Challenges at End-of-Life Amanda Lovell, PharmD, BCGP Clinical Pharmacist- Inpatient Units Optum Hospice Pharmacy Services February 15, 2018 Hospice Pharmacy Services Objectives Identify

More information

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist

Intervention Study 2016 West ISD. Gillian Ritchie Clinical Pharmacist Intervention Study 2016 West ISD Gillian Ritchie Clinical Pharmacist Introduction Annual data collection Two weeks All Medicines Management Team interventions Details recorded Classified by type Outcomes

More information

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults

Disclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults Medication Management in the Elderly Disclosures Melissa Stevens MD Atlanta VA Medical Center Assistant Professor Emory University Department of Medicine I have no significant financial interest or other

More information

Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals

Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management The Johns Hopkins Hospital Objectives and Disclosures

More information

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR: M0BCore Safety Profile Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg P-RMS: FR/H/PSUR/0066/001 Date of FAR: 26.11.2013 4.3 Contraindications Bromazepam must not be administered

More information

Primary Screening and Ongoing Assessment, Diagnosis and Interventions

Primary Screening and Ongoing Assessment, Diagnosis and Interventions Primary Screening and Ongoing Assessment, Diagnosis and Interventions Vicky Scott, RN, PhD Clinical Professor, School of Population and Public Health Faculty of Medicine, University of British Columbia

More information

Rule Governing the Prescribing of Opioids for Pain

Rule Governing the Prescribing of Opioids for Pain Rule Governing the Prescribing of Opioids for Pain 1.0 Authority This rule is adopted pursuant to Sections 14(e) and 11(e) of Act 75 (2013) and Sections 2(e) and 2a of Act 173 (2016). 2.0 Purpose This

More information

Psychotropic Medication. Including Role of Gradual Dose Reductions

Psychotropic Medication. Including Role of Gradual Dose Reductions Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which

More information

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES

More information

Management of Delirium in Hospice Patients

Management of Delirium in Hospice Patients Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying

More information

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace

Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace Aging and Geriatric Assessment Page 1 Aging and Geriatric Assessment March 31, 2008 Sharon Leigh, Pharm D. BCPS Providence ElderPlace I. Aging A. Demographics Age 65+ population 3.1 million 1900 31.2 million

More information

Safe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA

Safe and Effective Use of. Psychotropic Drugs. Introduction. Psychotropic Drugs. Jun NAKAMURA Psychotropic Drugs Safe and Effective Use of Psychotropic Drugs JMAJ 47(6): 259 264, 2004 Jun NAKAMURA Professor, Department of Psychiatry, School of Medicine, University of Occupational and Environmental

More information

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services DRIVING AND MENTAL HEALTH CONDITIONS AND TREATMENTS General information Driving while impaired by a physical

More information

Preven&on of Falls in Older Adults

Preven&on of Falls in Older Adults David Ganz, MD, PhD Staff Physician, VA Greater Los Angeles Assistant Professor of Medicine, UCLA Preven&on of Falls in Older Adults No conflicts of interest to disclose Objectives Detail the evidence-based

More information

Jefferson In the News!

Jefferson In the News! Evaluation of a Pharmacist-led Medication Assessment to Identify the Prevalence of Polypharmacy and Potentially Inappropriate Medication (PIM) Use Among Ambulatory Seniors with Cancer Ginah Nightingale,

More information

From the Front Lines AlixaRx Clinical Pharmacists Address Everyday Challenges in Long-Term Care

From the Front Lines AlixaRx Clinical Pharmacists Address Everyday Challenges in Long-Term Care May 2015 Issue From the Front Lines AlixaRx Clinical Pharmacists Address Everyday Challenges in Long-Term Care Behavior Monitoring When is behavior monitoring required? In Long-term care, medications are

More information

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected. KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised

More information

Dosing & Administration

Dosing & Administration Dosing & Administration REAL LIFE. REAL RESULTS. INDICATION INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia. Schizoaffective disorder as monotherapy and as an

More information